Top Markets
Coin of the day
INOVIQ Ltd INOVIQ Ltd

INOVIQ Ltd

IIQ
Rangering i aksjer #29959
INOVIQ Ltd specializes in the research, development, and commercialization of... INOVIQ Ltd specializes in the research, development, and commercialization of diagnostic and exosome-based products, aiming to improve the detection and treatment of cancer and other conditions across Australia and the United States. Its current portfolio includes the hTERT test, an immunocytochemistry assay that serves as a supplementary tool for urine cytology in bladder cancer screening, alongside EXO-NET, designed for the capture and isolation of exosomes from liquid biopsy specimens. The company also boasts a robust diagnostic pipeline, featuring blood tests currently under development for various cancers, including ovarian and breast cancer. Originally incorporated in 1983 and formerly known as BARD1 Life Sciences Limited until its rebranding to INOVIQ Ltd in December 2021, the company maintains its headquarters in Notting Hill, Australia.
Aksjekurs
$0.13400411
Markedsverdi
$18.86M
Endring (1 dag)
2.70%
Endring (1 år)
-48.10%
Land
AU
Handel INOVIQ Ltd (IIQ)

Kategori

Aksjeprishistorikk for INOVIQ Ltd (IIQ)
Høyeste sluttskurs: $0.14 den 2026-08-01

Laveste sluttskurs: $166.60 den 1988-01-01
Aksjeprishistorikk for INOVIQ Ltd fra 1988 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 1.45%
2025 -30.46%
2024 -24.16%
2023 -0.02%
2022 -43.77%
2021 47.46%
2020 -21.25%
2019 50.59%
2018 181.83%
2017 -75.39%
2016 1.49%
2015 -12.13%
2014 16.04%
2013 -70.72%
2012 -55.14%
2011 -15.17%
2010 21.81%
2009 212.35%
2008 -62.47%
2007 -25.96%
2006 -63.96%
2005 -46.59%
2004 79.49%
2003 90.17%
2002 26.00%
2001 -70.94%
2000 -51.79%
1999 -19.50%
1998 26.20%
1997 -22.09%
1996 77.59%
1995 -11.75%
1994 -13.96%
1993 107.22%
1992 31.18%
1991 187.46%
1990 -83.26%
1989 -66.96%
1988 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$591.22 18.65%
US
$200.34 -5.59%
US
$23.62 87.95%
CN
$312.51 95.17%
US
$557.21 -12.49%
US